Skip to main content

Series A Therapeutics Companies

Explore 233 therapeutics startups that raised series a funding. Access verified founder contact information and fundraising data.

Total Companies
233
Total Funding
$1.3B
Avg Funding
$52.5M
Cities
20

Export 233 Series A Therapeutics Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
Raleigh, United States
$130.0M
raised

Slate Medicines develops therapeutics that target Pituitary Adenylate Cyclase-Activating Polypeptide for migraine treatment and prevention.

Feb 2026
Series A

Founder Contacts

41,000+ verified contacts

Alderley Park, United Kingdom
$8.1M
raised

Centauri Therapeutics is a UK-based biotechnology company focused on the discovery and development of life threatening diseases.

Feb 2026
Series A

Founder Contacts

41,000+ verified contacts

Phoenix, United States
$60.0M
raised

Breakthru Medicine develops novel therapeutic modalities aimed at treating cancer by targeting hard-to-drug disease mechanisms.

Jan 2026
Series A

Founder Contacts

41,000+ verified contacts

Boulder, United States
$55.0M
raised

Think Bioscience is reimagining synthetic biology by guiding the design and assembly of better medicines through the use of living systems.

Jan 2026
Series A

Founder Contacts

41,000+ verified contacts

Recoleta, Argentina
$8.0M
raised

BIOMAKERS is a biotechnology research company that offers molecular testing and genetic diagnosis for patient treatment.

Jan 2026
Series A

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 233 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Palo Alto, United States
$200.0M
raised

AirNexis Therapeutics develops clinical-stage therapies for chronic obstructive pulmonary disease and other pulmonary conditions.

Jan 2026
Series A

Founder Contacts

41,000+ verified contacts

Quebec, Canada
$7.2M
raised

Find therapeutics is operator of a drug discovery and development company intended to emerge with a new therapeutic modality.

Jan 2026
Series A

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$50.0M
raised

Poplar Therapeutics anti-IgE therapy treats atopic diseases such as food allergy, allergic asthma, and atopic dermatitis.

Jan 2026
Series A

Founder Contacts

41,000+ verified contacts

Irvine, United States
$125.0M
raised

Ambros Therapeutics is a clinical-stage biotechnology company.

Dec 2025
Series A

Founder Contacts

41,000+ verified contacts

San Francisco, United States
$70.0M
raised

ProLynx is a biotechnology company that develops proprietary drug-delivery technologies to extend the half-life of therapeutic molecules.

Dec 2025
Series A

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 233 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Watertown, United States
$47.5M
raised

Psivant Therapeutics is a biotechnology company that offers drug design, biology research, and development services.

Dec 2025
Series A

Founder Contacts

41,000+ verified contacts

Bethesda, United States
$20.0M
raised

Aradigm Health platform enables access to next generation of transformative therapies—cell and gene therapies (CGTs).

Dec 2025
Series A

Founder Contacts

41,000+ verified contacts

Albuquerque, United States
$15.0M
raised

Circular Genomics is a biotechnology and genomics company that develops RNA-based diagnostics for neurological diseases.

Dec 2025
Series A

Founder Contacts

41,000+ verified contacts

Crown Point, United States
$5.5M
raised

OYE Therapeutics is a clinical-stage pharmaceutical development company that develops anesthesia drugs.

Nov 2025
Series A

Founder Contacts

41,000+ verified contacts

Boston, United States
$41.5M
raised

AI Proteins is a biotechnology company that focuses on the de novo design and engineering of miniprotein therapeutics.

Nov 2025
Series A

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 233 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
San Francisco, United States
$185.0M
raised

Braveheart Bio is a clinical-stage biotechnology company focused on developing precision therapies in the cardiovascular disease space.

Nov 2025
Series A

Founder Contacts

41,000+ verified contacts

San Francisco, United States
$25.0M
raised

Faeth Therapeutics is a cancer metabolism company that focuses on nutrition treatments for cancer patients.

Oct 2025
Series A

Founder Contacts

41,000+ verified contacts

New York, United States
$101.0M
raised

NILO Therapeutics is a biotechnology and therapeutics company.

Oct 2025
Series A

Founder Contacts

41,000+ verified contacts

Edinburgh, United Kingdom
$94.1M
raised

Trogenix is a biotech company that develops precision cancer treatments that selectively target diseased cell states and behaviour.

Oct 2025
Series A

Founder Contacts

41,000+ verified contacts

Boston, United States
$23.4M
raised

Predicta Biosciences provides molecular diagnostics and immunotherapeutic discovery services for hematological diseases.

Oct 2025
Series A

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 233 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Raleigh, United States
$5.0M
raised

Evecxia Therapeutics is a pharmaceutical company that develops drugs to help patients suffering from disabling neuropsychiatric conditions.

Sep 2025
Series A

Founder Contacts

41,000+ verified contacts

Tokyo, Japan
$3.1M
raised

FerroptoCure is a research firm that specializes in ferroptosis research and the development of therapeutic drugs to treat diseases.

Sep 2025
Series A

Founder Contacts

41,000+ verified contacts

Vestavia Hills, United States
$8.0M
raised

ResBiotic develops probiotic and pharmabiotic therapies to alleviate neutrophilic inflammation associated with dysbiosis.

Sep 2025
Series A

Founder Contacts

41,000+ verified contacts

Boston, United States
$25.0M
raised

Sensorium Therapeutics is a drug discovery platform that develops novel FDA-approved psychoactive medicines.

Aug 2025
Series A

Founder Contacts

41,000+ verified contacts

Wilmington, United States
$1.0M
raised

CorriXR Therapeutics is a biotechnology company.

Aug 2025
Series A

Founder Contacts

41,000+ verified contacts

Showing 26 to 50 of 233 companies

Ready to Connect with Series A Therapeutics Startups?

Get verified founder emails, funding details, and company data for 233 series a therapeutics companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked